Study of work risks for bile duct and pancreas cancers
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at whether certain jobs or work conditions increase the risk of bile duct or pancreatic cancers. If you have one of these cancers and are already in another study, or if you are a healthy person in a comparison group, you might help researchers understand occupational risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have bile duct or pancreatic cancer and are in the TEDOPAM or IMMUNOBIL trials
- You have a complete work history that can be analyzed
- You are a healthy person age 18 or older in the CHOPPI cohort with no bile duct or pancreatic cancer and no known family risk
- You agree to have your data used for this research
- Your work history is not incomplete or unusable
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at factors in the family and the environment that may be linked to pancreatic cancer. It includes people with pancreatic cancer and several types of pancreas-related conditions, as well as some healthy volunteers, and may help researchers understand who is at higher risk.
This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.
This study collects health information and stored samples (biospecimens) to learn more about pancreatic diseases, including cancer and early warning changes. It may help researchers understand who is at higher risk and improve future testing and care.
This study looks at how certain substances in your blood and bacteria in your gut might help predict pancreatic cancer, especially in people with chronic pancreatitis. It aims to find early warning signs to catch cancer sooner.
This study looks at lab markers (including genetic tests) to predict how people with bile duct cancer respond to treatment. Your answers and samples may help doctors personalize care for bile duct cancer in the future.
This study analyzes immune system markers in blood samples to help predict which people with chronic pancreatitis (long-term pancreas inflammation) might develop pancreatic cancer. Researchers will compare blood patterns in healthy people, those with chronic pancreatitis, and those recently diagnosed with pancreatic cancer.
Hear when a new Biliary Tract Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.